Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA priority review
Pharma
Sarepta's Elevidys expansion bid gets fast review without adcomm
After Elevidys scored an FDA approval in a restricted group of patients, Sarepta's attempt for a larger indication has snared a priority review.
Zoey Becker
Feb 16, 2024 11:05am
FDA gives Eisai's Leqembi July 6 priority review date
Mar 6, 2023 11:45am
FDA grants Pfizer's Prevnar 20 priority review for pediatric use
Jan 6, 2023 10:20am
Regeneron's Evkeeza gets priority look for use in kids with HoFH
Nov 30, 2022 11:19am
Gilead's Trodelvy up for FDA breast cancer verdict in February
Oct 11, 2022 11:09am
Roche eyes year-end FDA bispecific verdict in lymphoma
Jul 6, 2022 10:15am
